On This episode of Stock Movers:
- BP agreed to sell a majority stake in its Castrol lubricants division to US investment firm Stonepeak Partners to raise about $6 billion.
- French biotech company Abivax started the year with a market value of less than $500 million. After a meteoric rally, it’s now worth more than $8 billion — and some analysts see the potential for even more gains
- B&M's stock has fallen 56% in 2025, extending the previous year’s 34% drop, as the firm struggles to contend with a cocktail of rising competition, increasing wage costs and a pinch on the low-income households that have been key to its past success.
See omnystudio.com/listener for privacy information.
